Skip to main content
. Author manuscript; available in PMC: 2019 Apr 18.
Published in final edited form as: Neuropharmacology. 2017 Aug 1;125:254–262. doi: 10.1016/j.neuropharm.2017.07.031

Table 3.

Modafinil does not significantly alter performance of the WCST.

Measure Mean (SEM) F p-value
Total Correct 0.73 0.49
 Placebo 48.3 (1.8)
 200 mg Modafinil 45.4 (3.1)
 400 mg Modafinil 46.6 (3.3)
Total Errors 0.75 0.48
 Placebo 15.6 (1.8)
 200 mg Modafinil 18.6 (3.1)
 400 mg Modafinil 17.4 (3.3)
% Perseverative Responses 0.91 0.41
 Placebo 37.4 (1.8)
 200 mg Modafinil 28.3 (8.8)
 400 mg Modafinil 44.6 (3.6)
% Perseverative Errors 1.04 0.36
 Placebo 35.2 (4.6)
 200 mg Modafinil 27.9 (7.8)
 400 mg Modafinil 45.1 (8.4)
% Nonperseverative Errors 0.09 0.91
 Placebo 50.6 (5.2)
 200 mg Modafinil 50.4 (8.8)
 400 mg Modafinil 54.3 (9.4)
Categories Completed 0.24 0.79
 Placebo 3.5 (0.3)
 200 mg Modafinil 3.3 (0.4)
 400 mg Modafinil 3.6 (0.5)
Trials to Complete 1st Category 1.95 0.15
 Placebo 14.2 (2.3)
 200 mg Modafinil 19.5 (3.8)
 400 mg Modafinil 21.3(4.1)